HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Amir Abdollahi Selected Research

Ions

10/2022FLASH with carbon ions: Tumor control, normal tissue sparing, and distal metastasis in a mouse osteosarcoma model.
10/2022Biological Dose Optimization for Particle Arc Therapy Using Helium and Carbon Ions.
9/2022Spot-scanning hadron arc (SHArc) therapy: A proof of concept using single- and multi-ion strategies with helium, carbon, oxygen, and neon ions.
1/2022Radioresistance and Transcriptional Reprograming of Invasive Glioblastoma Cells.
1/2022Combined DNA Damage Repair Interference and Ion Beam Therapy: Development, Benchmark, and Clinical Implications of a Mechanistic Biological Model.
12/2021Carbon ion radiotherapy eradicates medulloblastomas with chromothripsis in an orthotopic Li-Fraumeni patient-derived mouse model.
5/2021Spot-Scanning Hadron Arc (SHArc) Therapy: A Study With Light and Heavy Ions.
12/2020Mapping the Relative Biological Effectiveness of Proton, Helium and Carbon Ions with High-Throughput Techniques.
7/2019Biophysical modeling and experimental validation of relative biological effectiveness (RBE) for 4He ion beam therapy.
1/2019Carbon irradiation overcomes glioma radioresistance by eradicating stem cells and forming an antiangiogenic and immunopermissive niche.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Amir Abdollahi Research Topics

Disease

82Neoplasms (Cancer)
10/2022 - 07/2003
20Squamous Cell Carcinoma of Head and Neck
06/2022 - 12/2014
18Glioblastoma (Glioblastoma Multiforme)
10/2022 - 11/2004
13Glioma (Gliomas)
01/2022 - 12/2003
12Neoplasm Metastasis (Metastasis)
10/2022 - 01/2005
9Hypoxia (Hypoxemia)
01/2022 - 07/2012
9Fibrosis (Cirrhosis)
01/2021 - 10/2004
7Lung Neoplasms (Lung Cancer)
12/2020 - 07/2012
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2017 - 01/2011
5Meningioma (Meningiomas)
11/2021 - 03/2008
5Carcinoma (Carcinomatosis)
04/2021 - 07/2006
5Prostatic Neoplasms (Prostate Cancer)
01/2021 - 07/2003
5Head and Neck Neoplasms (Head and Neck Cancer)
12/2019 - 01/2016
4Pancreatic Neoplasms (Pancreatic Cancer)
05/2022 - 06/2009
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2018 - 07/2006
3Adenocarcinoma
10/2022 - 05/2022
3AIDS-Related Complex (ARC)
10/2022 - 05/2021
3Pulmonary Fibrosis (Fibrosing Alveolitis)
06/2010 - 03/2005
2Radiation Fibrosis Syndrome (Radiation Fibrosis)
03/2022 - 03/2006
2Lymphoma (Lymphomas)
01/2021 - 01/2018
2Melanoma (Melanoma, Malignant)
09/2020 - 07/2018
2Adenocarcinoma of Lung
01/2020 - 01/2017
2Inflammation (Inflammations)
04/2016 - 12/2009
2Carcinogenesis
01/2016 - 07/2012
2Body Weight (Weight, Body)
03/2007 - 01/2006
1Osteosarcoma (Osteogenic Sarcoma)
10/2022
1Chordoma
10/2022
1Chromothripsis
12/2021
1Medulloblastoma
12/2021
1Mitochondrial Diseases (Mitochondrial Disease)
11/2021

Drug/Important Bio-Agent (IBA)

21IonsIBA
10/2022 - 05/2012
21CarbonIBA
10/2022 - 05/2012
13Biomarkers (Surrogate Marker)IBA
01/2022 - 09/2015
13Proteins (Proteins, Gene)FDA Link
10/2021 - 01/2005
12DNA (Deoxyribonucleic Acid)IBA
01/2022 - 12/2014
11Protons (Proton)IBA
01/2021 - 05/2012
9Biological ProductsIBA
10/2022 - 02/2010
6HeliumIBA
10/2022 - 08/2016
6Messenger RNA (mRNA)IBA
11/2021 - 02/2009
6Pharmaceutical PreparationsIBA
11/2021 - 01/2005
6Cisplatin (Platino)FDA LinkGeneric
04/2021 - 12/2014
6Angiogenesis InhibitorsIBA
02/2010 - 07/2003
4Oxygen (Dioxygen)IBA
09/2022 - 08/2016
4Radiation-Sensitizing AgentsIBA
01/2022 - 01/2011
4RNA (Ribonucleic Acid)IBA
01/2020 - 06/2009
4Temozolomide (Temodar)FDA LinkGeneric
01/2020 - 09/2011
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2019 - 03/2008
4Semaxinib (SU5416)IBA
04/2008 - 07/2003
3Phosphotransferases (Kinase)IBA
11/2021 - 03/2007
3Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
11/2021 - 03/2006
3MicroRNAs (MicroRNA)IBA
03/2021 - 01/2012
3KinesinsIBA
01/2021 - 06/2009
3Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
10/2020 - 09/2011
3Small Interfering RNA (siRNA)IBA
04/2019 - 06/2009
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2016 - 01/2006
3Tyrosine Kinase InhibitorsIBA
02/2015 - 03/2007
3Imatinib Mesylate (Gleevec)FDA Link
12/2009 - 03/2006
3orantinib (SU6668)IBA
04/2008 - 07/2003
3Platelet-Derived Growth FactorIBA
04/2008 - 03/2005
2ErbB Receptors (EGF Receptor)IBA
05/2022 - 02/2009
2Cetuximab (Erbitux)FDA Link
05/2022 - 07/2018
2LigandsIBA
05/2022 - 08/2017
2GemcitabineFDA Link
05/2022 - 03/2012
2PPAR gammaIBA
01/2021 - 05/2010
2EnzymesIBA
11/2019 - 01/2014
2Caspase 3 (Caspase-3)IBA
01/2019 - 05/2005
2Anaplastic Lymphoma KinaseIBA
01/2018 - 02/2015
2Matrix Metalloproteinases (MMPs)IBA
01/2018 - 06/2010
2ParaffinIBA
01/2018 - 05/2016
2Formaldehyde (Formol)FDA Link
01/2018 - 05/2016
2Protein Kinases (Protein Kinase)IBA
12/2017 - 01/2014
2AntigensIBA
01/2017 - 01/2005
2CrizotinibIBA
02/2016 - 02/2015
2Immunosuppressive Agents (Immunosuppressants)IBA
01/2014 - 06/2008
2ThrombospondinsIBA
01/2012 - 02/2009
2AngiomotinsIBA
01/2012 - 01/2012
2Growth Factor ReceptorsIBA
01/2012 - 02/2010
2Tissue Inhibitor of Metalloproteinase-3IBA
01/2012 - 02/2009
2Celecoxib (Celebrex)FDA Link
01/2011 - 01/2006
2Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
01/2011 - 01/2006
2matrigelIBA
05/2010 - 07/2003
2PDGF receptor tyrosine kinaseIBA
12/2009 - 03/2005
2AngiostatinsIBA
08/2009 - 02/2009
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2009 - 07/2003
2SU 11657IBA
03/2008 - 05/2005
1salicylhydroxamic acid (SHAM)IBA
10/2022
1Poly(ADP-ribose) Polymerase InhibitorsIBA
12/2021
1Bromodeoxyuridine (BrdU)IBA
11/2021
1Gentian Violet (Violet, Crystal)FDA Link
11/2021
1ponatinibIBA
11/2021
1tyrosine receptor (receptor, tyrosine)IBA
11/2021
1Cell-Free Nucleic AcidsIBA
01/2021

Therapy/Procedure

45Therapeutics
10/2022 - 12/2003
38Radiotherapy
06/2022 - 07/2003
17Chemoradiotherapy
01/2022 - 12/2014
16Drug Therapy (Chemotherapy)
06/2022 - 11/2004
5Heavy Ion Radiotherapy
01/2022 - 01/2018
5Immunotherapy
03/2021 - 01/2005
2Neoadjuvant Therapy
05/2016 - 03/2012
1Transplantation
01/2022